Teramoto, T., Kondo, A., Kiyosue, A., Harada-Shiba, M., Ishigaki, Y., Tobita, K., . . . Sata, M. (2017). Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale. Lipids Health Dis.
シカゴスタイル引用形Teramoto, Tamio, et al. "Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid-lowering Therapy or the Lowest Strength of Statin: ODYSSEY NIPPON Study Design and Rationale." Lipids Health Dis 2017.
MLA引用形式Teramoto, Tamio, et al. "Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid-lowering Therapy or the Lowest Strength of Statin: ODYSSEY NIPPON Study Design and Rationale." Lipids Health Dis 2017.